Clustering of psychiatric and somatic illnesses in the general population: Multimorbidity and socioeconomic correlates

Brazilian Journal of Medical and Biological Research

Volumn 43, Issue 5, 2010, Pages 483-491

  Andrade, L H ^a   Bensenor I M ^a   Viana, M C ^a   Andreoni, S ^b   Wang, Y P ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chronic medical illness; Common psychological symptoms; Comorbidity; Multimorbidity coefficient; Negative binomial regression; Socioeconomic status

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DISTRESS SYNDROME; EMPLOYMENT STATUS; FEMALE; HUMAN; MALE; MARRIAGE; MENTAL DISEASE; MORBIDITY; PENSIONER; RISK FACTOR; SEX DIFFERENCE; SOCIOECONOMICS; STUDENT;

EID: 77952894583     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2010007500024     Document Type: Article

References (40)

1. United Nations Development Programme. Human development report 2003 - Millennium Development Goals: A compact among nations to end human poverty. http://hdr.undp.org/en/reports/global/hdr2003/
2. Neeleman J, Ormel J, Bijl RV. The distribution of psychiatric and somatic III health: associations with personality and socioeconomic status. Psychosom Med 2001; 63: 239-247.
3. Neeleman J, Sytema S, Wadsworth M. Propensity to psychiatric and somatic ill-health: evidence from a birth cohort. Psychol Med 2002; 32: 793-803.
4. Neeleman J, Bijl R, Ormel J. Neuroticism, a central link between somatic and psychiatric morbidity: path analysis of prospective data. Psychol Med 2004; 34: 521-531.
5. Batstra L, Bos EH, Neeleman J. Quantifying psychiatric comorbidity-lessons from chronic disease epidemiology. Soc Psychiatry Psychiatr Epidemiol 2002; 37: 105-111.
6. Rhee SH, Hewitt JK, Corley RP, Willcutt EG, Pennington BF. Testing hypotheses regarding the causes of comorbidity: examining the underlying deficits of comorbid disorders. J Abnorm Psychol 2005; 114: 346-362.
7. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity. a critical review of available methods. J Clin Epidemiol 2003; 56: 221-229.
8. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 617-627.
9. Andrade L, Walters EE, Gentil V, Laurenti R. Prevalence of ICD-10 mental disorders in a catchment area in the city of São Paulo, Brazil. Soc Psychiatry Psychiatr Epidemiol 2002; 37: 316-325.
10. Andrade LH, Viana MC, Tofoli LF, Wang YP. Influence of psychiatric morbidity and sociodemographic determinants on use of service in a catchment area in the city of São Paulo, Brazil. Soc Psychiatry Psychiatr Epidemiol 2008; 43: 45-53.
11. Fundação IBGE. Censo 2000. http://www.ibge.com.br/home/estatistica/populacao/default_censo_2000.shtm
12. Kish L, Frankel MR. Balanced repeated replications for standard errors. JASA 1970; 65: 1071-1094.
13. Lopes CS. Reliability of the Brazilian version of the CIDI in a case-control study of risk factors for drug abuse among adults in Rio de Janeiro. Bull Pan Am Health Organ 1994; 28: 34-41.
14. Robins LN, Wing J, Wittchen HU, Helzer JE, Babor TF, Burke J, et al. The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry 1988; 45: 1069-1077.
15. World Health Organization. International Statistical Classification of Diseases and Related Heath Problems, 10th revision. Geneva: WHO; 1992
16. Reed V, Wittchen HU. DSM-IV panic attacks and panic disorder in a community sample of adolescents and young adults: how specific are panic attacks? J Psychiatr Res 1998; 32: 335-345.
17. Andrade L, Eaton WW, Chilcoat HD. Lifetime co-morbidity of panic attacks and major depression in a population-based study: age of onset. Psychol Med 1996; 26: 991-996.
18. Watson D, Clark LA. Negative affectivity: the disposition to experience aversive emotional states. Psychol Bull 1984; 96: 465-490.
19. Korten A, Henderson S. The Australian National Survey of Mental Health and Well-Being. Common psychological symptoms and disablement. Br J Psychiatry 2000; 177: 325-330.
20. van den Akker M, Buntinx F, Metsemakers JF, Roos S, Knottnerus JA. Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol 1998; 51: 367-375.
21. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular survey methods. Geneva: WHO; 1982
22. SAS Institute Inc. SAS/STAT® User's Guide, Version 8. Cary: SAS Institute Inc.; 1999
23. Goldberg DP, Krueger RF, Andrews G, Hobbs MJ. Emotional disorders: cluster 4 of the proposed meta-structure for DSMV and ICD-11. Psychol Med 2009; 39: 2043-2059.
24. Krueger RF, South SC. Externalizing disorders: cluster 5 of the proposed meta-structure for DSM-V and ICD-11. Psychol Med 2009; 39: 2061-2070.
25. Haug TT, Mykletun A, Dahl AA. The association between anxiety, depression, and somatic symptoms in a large population: the HUNT-II study. Psychosom Med 2004; 66: 845-851.
26. Goodwin RD, Jacobi F, Thefeld W. Mental disorders and asthma in the community. Arch Gen Psychiatry 2003; 60: 1125-1130.
27. Feldman JM, Siddique MI, Morales E, Kaminski B, Lu SE, Lehrer PM. Psychiatric disorders and asthma outcomes among high-risk inner-city patients. Psychosom Med 2005; 67: 989-996.
28. Ostir GV, Goodwin JS. High anxiety is associated with an increased risk of death in an older tri-ethnic population. J Clin Epidemiol 2006; 59: 534-540.
29. Yasunari K, Matsui T, Maeda K, Nakamura M, Watanabe T, Kiriike N. Anxiety-induced plasma norepinephrine augmentation increases reactive oxygen species formation by monocytes in essential hypertension. Am J Hypertens 2006; 19: 573-578.
30. Rutledge T, Hogan BE. A quantitative review of prospective evidence linking psychological factors with hypertension development. Psychosom Med 2002; 64: 758-766.
31. Lotufo PA, Benseñor IM. Smoking and mortality from cerebrovascular disorders in Brazil: comparative study of capital cities of metropolitan regions, 1988. Arq Neuropsiquiatr 1995; 53: 238-244.
32. Hagen EM, Svensen E, Eriksen HR, Ihlebaek CM, Ursin H. Comorbid subjective health complaints in low back pain. Spine 2006; 31: 1491-1495.
33. Kraemer HC, Wilson KA, Hayward C. Lifetime prevalence and pseudocomorbidity in psychiatric research. Arch Gen Psychiatry 2006; 63: 604-608.
34. Kriegsman DM, Penninx BW, van Eijk JT, Boeke AJ, Deeg DJ. Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients' self-reports and on determinants of inaccuracy. J Clin Epidemiol 1996; 49: 1407-1417.
35. Armenian HK, Pratt LA, Gallo J, Eaton WW. Psychopathology as a predictor of disability: a population-based follow-up study in Baltimore, Maryland. Am J Epidemiol 1998; 148: 269-275.
36. Buist-Bouwman MA, de Graaf R, Vollebergh WA, Alonso J, Bruffaerts R, Ormel J. Functional disability of mental disorders and comparison with physical disorders: a study among the general population of six European countries. Acta Psychiatr Scand 2006; 113: 492-500.
37. Lopez A, Mathers C, Ezzati M, Jamison D, Murray C. Global burden of disease and risk factors. Washington: Oxford University Press and the World Bank; 2006
38. World Health Organization. Mental health atlas, 2005. http://www.who.int/mental_health/evidence/mhatlas05/en/index.html
39. Miranda JJ, Patel V. Achieving the Millennium Development Goals: does mental health play a role? PLoS Med 2005; 2: e291
40. Eisenberg L. Mindlessness and brainlessness in psychiatry. Br J Psychiatry 1986; 148: 497-508.